News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|March 1, 2006

Upcoming for ADHD meds: Black box warning?

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Weekly review: Formula recall, FDA warning for bassinet, and more

Weekly review: Formula recall, FDA warning for bassinet, and more

ByMorgan Ebert, Executive Editor

June 19th 2026

Cadrenal plans FDA rare pediatric disease request for tecarfarin in Kawasaki disease

ByBenjamin P. Saylor

June 19th 2026

Empowering underserved children through representation, health literacy, and trusted content | Image credit: The Doctor Is In

Empowering underserved children through representation, health literacy, and trusted content

ByJosé Morey, MD,Joel Bervell, MD

June 19th 2026

FDA approves generic baloxavir marboxil for flu treatment, prophylaxis

ByBenjamin P. Saylor

June 18th 2026

Spinal muscular atrophy pharmacotherapy: Getting an earlier start | Image Credit: © Rochu_2008 - stock.adobe.com.

Spinal muscular atrophy pharmacotherapy: Getting an earlier start

ByLauren Prack, PharmD

June 18th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C

FDA issues Warning Letter to SNOO Smart Sleeper maker over unauthorized sleep sacks, hospital bundle, and quality system failures

Empowering underserved children through representation, health literacy, and trusted content

Weekly review: Formula recall, FDA warning for bassinet, and more

Cadrenal plans FDA rare pediatric disease request for tecarfarin in Kawasaki disease